<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05704808003021</udiDi>
    <basicUdiDi>B-05704808003021</basicUdiDi>
    <tradeName>ArthroZheal® Preparation Kit</tradeName>
    <deviceName>ArthroZheal® Preparation Kit</deviceName>
    <manufacturerName>Vivostat A/S</manufacturerName>
    <manufacturerSrn>DK-MF-000019521</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AZ 506</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-17T11:58:48.987Z</lastUpdated>
  </row>
  <row>
    <udiDi>05704808000594</udiDi>
    <basicUdiDi>B-05704808000594</basicUdiDi>
    <tradeName>Vivostat® PRF Preparation Kit</tradeName>
    <deviceName>Vivostat® PRF Preparation Kit</deviceName>
    <manufacturerName>Vivostat A/S</manufacturerName>
    <manufacturerSrn>DK-MF-000019521</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VS 406</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-17T11:58:48.189Z</lastUpdated>
  </row>
  <row>
    <udiDi>05704808000495</udiDi>
    <basicUdiDi>B-05704808000495</basicUdiDi>
    <tradeName>Vivostat® Fibrin Preparation Kit</tradeName>
    <deviceName>Vivostat® Fibrin Preparation Kit</deviceName>
    <manufacturerName>Vivostat A/S</manufacturerName>
    <manufacturerSrn>DK-MF-000019521</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VS 306</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-17T11:58:44.185Z</lastUpdated>
  </row>
  <row>
    <udiDi>08056992330429</udiDi>
    <basicUdiDi>803377232PRT-PRORP</basicUdiDi>
    <tradeName>PROTSMARTTM  4</tradeName>
    <deviceName>PROTSMART</deviceName>
    <manufacturerName>Medica S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000025691</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>M90431</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:43:34.764Z</lastUpdated>
  </row>
  <row>
    <udiDi>08056992335134</udiDi>
    <basicUdiDi>803377232PRT-PRORP</basicUdiDi>
    <tradeName>PCX</tradeName>
    <deviceName>PROTSMART</deviceName>
    <manufacturerName>Medica S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000025691</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>M90658</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-16T08:54:21.743Z</lastUpdated>
  </row>
  <row>
    <udiDi>08056992331488</udiDi>
    <basicUdiDi>803377232PRT-EXOQJ</basicUdiDi>
    <tradeName>EXOSMART</tradeName>
    <deviceName>EXOSMART</deviceName>
    <manufacturerName>Medica S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000025691</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>M90464</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-16T08:54:20.945Z</lastUpdated>
  </row>
  <row>
    <udiDi>08051418470987</udiDi>
    <basicUdiDi>805141847EASYPRPN2</basicUdiDi>
    <tradeName>EASY PRP</tradeName>
    <deviceName>EASY PRP provetta</deviceName>
    <manufacturerName>MESOTECH SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000011007</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EAS001</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-16T08:52:05.505Z</lastUpdated>
  </row>
  <row>
    <udiDi>08056992335141</udiDi>
    <basicUdiDi>803377232PRT-EXOQJ</basicUdiDi>
    <tradeName>SecretOne</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Medica S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000025691</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>M90659</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-09T19:55:48.213Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640138981289</udiDi>
    <basicUdiDi>B-07640138981289</basicUdiDi>
    <tradeName>RegenKit-THT-2</tradeName>
    <deviceName>RegenKit-THT-2</deviceName>
    <manufacturerName>Regen Lab SA</manufacturerName>
    <manufacturerSrn>CH-MF-000032231</manufacturerSrn>
    <authorisedRepresentativeName>RegenLab France</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000011953</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RK-THT-2</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T02:44:06.434Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640138981234</udiDi>
    <basicUdiDi>B-07640138981234</basicUdiDi>
    <tradeName>RegenKit-BCT-3</tradeName>
    <deviceName>RegenKit-BCT-3</deviceName>
    <manufacturerName>Regen Lab SA</manufacturerName>
    <manufacturerSrn>CH-MF-000032231</manufacturerSrn>
    <authorisedRepresentativeName>RegenLab France</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000011953</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RK-BCT-3</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T02:44:04.872Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640138981258</udiDi>
    <basicUdiDi>B-07640138981258</basicUdiDi>
    <tradeName>RegenKit-THT-3</tradeName>
    <deviceName>RegenKit-THT-3</deviceName>
    <manufacturerName>Regen Lab SA</manufacturerName>
    <manufacturerSrn>CH-MF-000032231</manufacturerSrn>
    <authorisedRepresentativeName>RegenLab France</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000011953</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RK-THT-3</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T02:44:02.432Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640138981210</udiDi>
    <basicUdiDi>B-07640138981210</basicUdiDi>
    <tradeName>RegenKit-BCT-2</tradeName>
    <deviceName>RegenKit-BCT-2</deviceName>
    <manufacturerName>Regen Lab SA</manufacturerName>
    <manufacturerSrn>CH-MF-000032231</manufacturerSrn>
    <authorisedRepresentativeName>RegenLab France</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000011953</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RK-BCT-2</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T02:44:01.385Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640138981227</udiDi>
    <basicUdiDi>B-07640138981227</basicUdiDi>
    <tradeName>RegenKit-BCT-2 Plus</tradeName>
    <deviceName>RegenKit-BCT-2 Plus</deviceName>
    <manufacturerName>Regen Lab SA</manufacturerName>
    <manufacturerSrn>CH-MF-000032231</manufacturerSrn>
    <authorisedRepresentativeName>RegenLab France</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000011953</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RK-BCT-2A</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T02:44:00.964Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640138981197</udiDi>
    <basicUdiDi>B-07640138981197</basicUdiDi>
    <tradeName>RegenKit-BCT-1</tradeName>
    <deviceName>RegenKit-BCT-1</deviceName>
    <manufacturerName>Regen Lab SA</manufacturerName>
    <manufacturerSrn>CH-MF-000032231</manufacturerSrn>
    <authorisedRepresentativeName>RegenLab France</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000011953</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RK-BCT-1</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T02:43:44.778Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640138981043</udiDi>
    <basicUdiDi>B-07640138981043</basicUdiDi>
    <tradeName>RegenKit-THT-4</tradeName>
    <deviceName>RegenKit-THT-4</deviceName>
    <manufacturerName>Regen Lab SA</manufacturerName>
    <manufacturerSrn>CH-MF-000032231</manufacturerSrn>
    <authorisedRepresentativeName>RegenLab France</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000011953</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RK-THT-4</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T02:43:37.569Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640138981036</udiDi>
    <basicUdiDi>B-07640138981036</basicUdiDi>
    <tradeName>RegenKit-THT-1</tradeName>
    <deviceName>RegenKit-THT-1</deviceName>
    <manufacturerName>Regen Lab SA</manufacturerName>
    <manufacturerSrn>CH-MF-000032231</manufacturerSrn>
    <authorisedRepresentativeName>RegenLab France</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000011953</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RK-THT-1</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T02:43:35.971Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640138980831</udiDi>
    <basicUdiDi>B-07640138980831</basicUdiDi>
    <tradeName>RegenKit-BCT-T</tradeName>
    <deviceName>RegenKit-BCT-T</deviceName>
    <manufacturerName>Regen Lab SA</manufacturerName>
    <manufacturerSrn>CH-MF-000032231</manufacturerSrn>
    <authorisedRepresentativeName>RegenLab France</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000011953</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RK-BCT-T</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T02:43:25.440Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640138980756</udiDi>
    <basicUdiDi>B-07640138980756</basicUdiDi>
    <tradeName>RegenKit-THT-2 Plus</tradeName>
    <deviceName>RegenKit-THT-2 Plus</deviceName>
    <manufacturerName>Regen Lab SA</manufacturerName>
    <manufacturerSrn>CH-MF-000032231</manufacturerSrn>
    <authorisedRepresentativeName>RegenLab France</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000011953</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RK-THT-2A</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T02:43:23.929Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640138980725</udiDi>
    <basicUdiDi>B-07640138980725</basicUdiDi>
    <tradeName>RegenKit Extracell Membrane</tradeName>
    <deviceName>RegenKit Extracell Membrane</deviceName>
    <manufacturerName>Regen Lab SA</manufacturerName>
    <manufacturerSrn>CH-MF-000032231</manufacturerSrn>
    <authorisedRepresentativeName>RegenLab France</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000011953</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>R-EXM/T</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T02:43:20.078Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640138980718</udiDi>
    <basicUdiDi>B-07640138980718</basicUdiDi>
    <tradeName>RegenFibrin Polymer 2</tradeName>
    <deviceName>RegenFibrin Polymer 2</deviceName>
    <manufacturerName>Regen Lab SA</manufacturerName>
    <manufacturerSrn>CH-MF-000032231</manufacturerSrn>
    <authorisedRepresentativeName>RegenLab France</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000011953</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B0599</emdnCode>
    <emdnDescription>TOPICAL USE BLOOD COMPONENTS PREPARATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>R-FP2/T</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T02:43:19.643Z</lastUpdated>
  </row>
</eudamedExport>